Skip to main content
. 2019 Aug 26;18:1533033819869949. doi: 10.1177/1533033819869949

Figure 4.

Figure 4.

Kaplan-Meier analysis for the prognostic value of immune stimulators (A) and immune inhibitors (B) in GBM. Statistical significance was determined by the Wilcoxon test (***P < .001, **P < .01, *P < .05). GBM indicates glioblastoma.